ORIZURU THERAPEUTICS
Orizuru Therapeutics is a cell-related technology firm that provides regenerative medicine and cell transplantation.
ORIZURU THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2021-04-09
Address:
Japan, Jawa Tengah, Indonesia
Country:
Indonesia
Website Url:
http://www.orizuru-therapeutics.com
Status:
Active
Similar Organizations
Aspron Healthcare
Aspron Healthcare is a pharmaceutical company that produces generic medicines.
Xellera Therapeutics
Xellera Therapeutics is a biotechnology company discovers and develops therapeutic and regenerative medicine for the treatment of diseases.
Official Site Inspections
http://www.orizuru-therapeutics.com
- Host name: ec2-3-114-86-243.ap-northeast-1.compute.amazonaws.com
- IP address: 3.114.86.243
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "Orizuru Therapeutics"
Orizuru Therapeutics - Crunchbase Company Profile
Organization. Orizuru Therapeutics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Orizuru Therapeutics is a cell-related technology firm that provides regenerative medicine and cell โฆSee details»
ORIZURU THERAPEUTICS
The Forum for Innovative Regenerative Medicine (FIRM) Ver.1.0 โฆ
Brief Descriptions of Organization* (Approx. 100 words) This company is a spinout from Takeda Pharmaceuticals and Kyoto University, focusing on the development of ... OZTx-556 will โฆSee details»
Orizuru Therapeutics Company Profile 2024: Valuation, โฆ
Orizuru Therapeutics General Information Description. Developer of cell-related therapeutics designed for regenerative medicine products and cell transplantation. The company engages in the research and development of โฆSee details»
#22 Realizing Clinical Application of iPS Cells and โฆ
Established in April 2021, Orizuru Therapeutics ("Orizuru Tx") aims to commercialize regenerative medicine and other products derived from iPS cells. ... It is important for both the individual and the organization to have this โฆSee details»
Our Business - ORIZURU THERAPEUTICS
What is iPIC. iPICs are human iPS cell-derived pancreatic islet cells expected to be suitable for cell therapy. They were discovered after a five-year optimization study through T-CiRA based on the pancreatic cell differentiation method โฆSee details»
Orizuru Therapeutics, Inc. - LinkedIn
Orizuru Therapeutics, Inc. Biotechnology Research Fujisawa, Kanagawa 152 followers R&D-driven company developing iPSCs to cure life-threatening diseases with large unmet needs.See details»
Orizuru Therapeutics, Inc. - BIO International Convention 2024
Jun 3, 2024 Orizuru Therapeutics Inc. was established in 2021 as a spinout from Takeda Pharmaceuticals and Kyoto University. The underlying technology is based on innovations โฆSee details»
Message by Orizuru Therapeutics, Inc. | P.S. i LOVE YOU PROJECT
About the organization Established in April 2021, Orizuru Therapeutics was founded to โbring hope for better health through the infinite power of science.โ It is developing regenerative โฆSee details»
Orizuru Therapeutics - VentureRadar
Orizuru Therapeutics promotes the social implementation of cell therapy products and innovative iPS cell related technologies (platform innovation). We are developing a definitive therapy for โฆSee details»
ORIZURU THERAPEUTICS
Orizuru Therapeutics aims to become a global leading company for clinical realization of iPS cell technology and provide solutions in all aspects of therapeutic R&D Concept behind the logo โฆSee details»
Establishment of Orizuru Therapeutics K.K. and Investment in the ...
Aug 10, 2021 We are very pleased that the innovative iPS cell research results from the T-CiRA program, in which academia and Takeda researchers work as one team, will be passed on to โฆSee details»
Orizuru Therapeutics Launches Operations as Research and โฆ
KYOTO, Japan, Aug. 10, 2021 /PRNewswire/ -- Orizuru Therapeutics Inc. ("OZTx") announced the launch of its operations on June 1, 2021. OZTx is a research and development-driven โฆSee details»
Orizuru Therapeutics Launches Operations as Research and โฆ
KYOTO, Japan, Aug. 10, 2021 /PRNewswire/ -- Orizuru Therapeutics Inc. ("OZTx") announced the launch of its operations on June 1, 2021. OZTx is a research and development-driven โฆSee details»
Nomura SPARX Invests in Orizuru Therapeutics | NOMURA
Tokyo, February 29, 2024 - Nomura SPARX Investment, Inc. (NSPI), a subsidiary of Nomura Holdings, Inc., today announced that an investment corporation managed by NSPI has โฆSee details»
ORIZURU THERAPEUTICS
Kyoto, Japan, August 10, 2021โOrizuru Therapeutics Inc. (โOZTxโ) announced the launch of its operations on June 1, 2021. OZTx is a research and development-driven company focusing โฆSee details»
PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint ...
Aug 24, 2023 About Orizuru Therapeutics, Inc. Name ๏ผOrizuru Therapeutics, Inc. Founded ๏ผApril 9 th, 2021. Address ๏ผ2-26-1 Muraoka-higashi, Fujisawa-shi, ...See details»
Orizuru Therapeutics Launches as R&D Company Focused on โฆ
Aug 15, 2021 Contributing to society and patients through the utilization of iPSC technology developed in Japan New company to advance two successful outcomes from T-CiRA โฆSee details»
ORIZURU THERAPEUTICS
Where we are aiming as a company is that โOrizuru Therapeutics will be the organization where any individuals are fully capable of self-management, as well as to maximize unique strengths โฆSee details»